Corporate News     28-Jan-22 Board of Accelya Solutions India recommends interim dividend Of Rs 17 per share Accelya Solutions India announced that the Board of Directors of the Company at its meeting held on 27 January 2022, inter alia, have recommended the interim dividend of Rs 17 per equity Share (i.e. 170%) , subject to the approval of the shareholders. Previous News   Accelya Solutions India consolidated net profit rises 55.64% in the December 2021 quarter  ( Results - Announcements 28-Jan-22   08:03 )   Accelya Solutions India announces cessation of director  ( Corporate News - 08-Jul-23   11:29 )   Accelya Solutions India consolidated net profit declines 86.52% in the June 2020 quarter  ( Results - Announcements 21-Aug-20   07:59 )   Accelya Solutions India consolidated net profit declines 4.77% in the September 2023 quarter  ( Results - Announcements 19-Oct-23   16:32 )   Board of Accelya Solutions India recommends Interim Dividend  ( Corporate News - 25-Jan-23   10:04 )   Accelya Solutions India to conduct board meeting  ( Corporate News - 19-Oct-21   14:33 )   Accelya Solutions India to hold AGM  ( Corporate News - 08-Oct-21   16:44 )   Accelya Solutions India to pay dividend  ( Market Beat - Reports 29-Aug-19   09:25 )   Accelya Kale Solutions consolidated net profit rises 14.77% in the December 2016 quarter  ( Results - Announcements 07-Feb-17   16:59 )   HFCL Ltd leads gainers in 'A' group  ( Hot Pursuit - 05-Jul-21   12:00 )   Accelya Solutions India update on holding company - Accelya Topco  ( Corporate News - 18-Nov-19   18:39 )	Other Stories   Mercury Trade Links to conduct EGM   15-Mar-25   20:06   Galada Finance to conduct board meeting   15-Mar-25   20:06   Board of Galaxy Surfactants recommends interim dividend   15-Mar-25   16:12   Heads UP Ventures announces board meeting date   15-Mar-25   16:12   Savera Industries to conduct board meeting   15-Mar-25   16:12   Strides Pharma Science announces acquisition of Singapore-based Amexel   15-Mar-25   15:45   Mphasis allots 99,115 equity shares under ESOP   15-Mar-25   15:43   Shilpa Pharma Lifesciences' Unit-2 clear USFDA inspection   15-Mar-25   15:40   Wipro grants 9,868 RSUs under ESOP   15-Mar-25   15:39   New Delhi Television announces resignation of director   15-Mar-25   15:38
Back Top